Literature DB >> 4098944

Levodopa in postencephalitic parkinsonism.

K R Hunter, G M Stern, J Sharkey.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1970        PMID： 4098944     DOI： 10.1016/s0140-6736(70)92398-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

Review 1.  Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

Authors:  R N Brogden; T M Speight; G S Avery
Journal:  Drugs       Date:  1971       Impact factor: 9.546

2.  Levodopa for parkinsonism.

Authors: 
Journal:  Br Med J       Date:  1971-01-30

3.  Supranuclear gaze palsy and eyelid apraxia in postencephalitic parkinsonism.

Authors:  G K Wenning; K Jellinger; I Litvan
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Response of patients with postencephalitic Parkinsonism to levodopa.

Authors:  R C Duvoisin; J Lobo-Antunes; M D Yahr
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-08       Impact factor: 10.154
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.